Aurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines for global markets. US pharma giant MSD is the first major client. The plant signifies Aurobindo's expansion into the growing biologics and contract manufacturing sector. It is set to create over 1,500 jobs.

TheraNyM Biologics opens a ₹1,200 crore facility near Hyderabad, with a potential to generate over 1,500 jobs

Aurobindo Pharma launches TheraNym, a biologics contract manufacturing organization, with MSD as its anchor customer in Hyderabad.

Aurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines for global markets. US pharma giant MSD…